Daniel  Tardiff net worth and biography

Daniel Tardiff Biography and Net Worth

Chief Scientific Officer of CAMP4 Therapeutics

Dan Tardiff, PhD, is Chief Scientific Officer of CAMP4 where he oversees Platform and Discovery Teams to expand the scope of CAMP4’s discovery platform and advance the pipeline towards the clinic.

Prior to joining CAMP4, Dr. Tardiff led drug discovery projects and teams in both small biotech and large pharma across multiple drug modalities. Dr. Tardiff most recently led a team in the Rare Disease Research Unit at Pfizer exploring genetic medicines for rare neurological disorders. Prior to Pfizer, Dr. Tardiff was a scientific co-founder of Yumanity Therapeutics, where he helped build a platform to discover novel therapeutics for the treatment of neurodegenerative diseases. At Yumanity, he led teams from screening through translational research to discover new therapeutic targets and drug candidates, including a clinical-stage small molecule targeting stearoyl-CoA desaturase for the potential treatment of Parkinson’s disease.

Dr. Tardiff earned his BS in Biochemistry from Stonehill College and his PhD from Brandeis University. He completed his post-doctoral training at the Whitehead Institute for Biomedical Research with Dr. Susan Lindquist.

How do I contact Daniel Tardiff?

The corporate mailing address for Dr. Tardiff and other CAMP4 Therapeutics executives is 15635 Alton Parkway Suite 250, Irvine CA, 92618. CAMP4 Therapeutics can also be reached via phone at (949) 600-5600 and via email at [email protected]. Learn More on Daniel Tardiff's contact information.

Has Daniel Tardiff been buying or selling shares of CAMP4 Therapeutics?

In the last ninety days, Daniel Tardiff has sold $8,272.88 of CAMP4 Therapeutics stock. Most recently, Daniel Tardiff sold 1,738 shares of the business's stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $4.76, for a transaction totalling $8,272.88. Learn More on Daniel Tardiff's trading history.

Who are CAMP4 Therapeutics' active insiders?

CAMP4 Therapeutics' insider roster includes Kurtis Binder (CFO), Jeffery Gardner (CEO), Kelly Gold (Chief Financial Officer), Josh Mandel-Brehm (President & Chief Executive Officer), Yuri Maricich (Chief Medical Officer), Amir Nashat (Director), Andrew Schwab (Director), Daniel Tardiff (Chief Scientific Officer), and Richard Young (Director). Learn More on CAMP4 Therapeutics' active insiders.

Are insiders buying or selling shares of CAMP4 Therapeutics?

During the last twelve months, CAMP4 Therapeutics insiders bought shares 11 times. They purchased a total of 5,624,916 shares worth more than $8,614,444.92. During the last twelve months, insiders at the Wireless communications provider sold shares 4 times. They sold a total of 193,603 shares worth more than $887,991.60. The most recent insider tranaction occured on August, 21st when Director Andrew J Schwab sold 32,018 shares worth more than $144,081.00. Insiders at CAMP4 Therapeutics own 21.7% of the company. Learn More about insider trades at CAMP4 Therapeutics.

Information on this page was last updated on 8/21/2026.

Daniel Tardiff Insider Trading History at CAMP4 Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/19/2026Sell1,738$4.76$8,272.88View SEC Filing Icon  
See Full Table

Daniel Tardiff Buying and Selling Activity at CAMP4 Therapeutics

This chart shows Daniel Tardiff's buying and selling at CAMP4 Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CAMP4 Therapeutics Company Overview

CAMP4 Therapeutics logo
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $4.33
Low: $4.26
High: $4.52

50 Day Range

MA: $4.12
Low: $3.01
High: $5.44

2 Week Range

Now: $4.33
Low: $1.41
High: $7.75

Volume

109,479 shs

Average Volume

228,934 shs

Market Capitalization

$271.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22